Citadel Advisors »

Biorestorative Therapies shares owned by Citadel Advisors

Quarter-by-quarter ownership of Biorestorative Therapies (BRTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Biorestorative Therapies

Tip: Access up to 7 years of quarterly data

All positions including Biorestorative Therapies held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biorestorative Therapies by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $65k 239k 0.27
2025-12-31 $34k 29k 1.17
2025-09-30 $152k 106k 1.43
2024-12-31 $31k 22k 1.43

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Biorestorative Therapies

Citadel Advisors
Geode Capital Management
UBS Group
Vanguard Group
Wealth Alliance
Vanguard Fiduciary Trust
State Street Corporation
Advisor Group Holdings
Tower Research Capital
SBI Securities
TD Waterhouse Canada
Caitong International Asset Management

View all funds holding Biorestorative Therapies